|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"楊志新"
Showing items 161-185 of 209 (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2007 |
Interim Safety Results from the East/South East (E/Se) Asian Subgroup of the Open-Label Trust (Tarceva Lung Cancer Survival Treatment) Study of Erlotinib for Advanced Non-Small-Cell Lung Cancer (Nsclc)
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
Met Amplification Occurs with or without T790m Mutations in Egfr Mutant Lung Tumors with Acquired Resistance to Gefitinib or Erlotinib
|
施金元; 張文誠; 余忠仁; 黃秀芬; 楊泮池; 楊志新; SHIH, JIN-YUAN; CHANG, WEN-CHENG; YU, CHONG-JEN; HUANG, SHIU-FENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2006 |
癌症的第四種治療：生物製劑治療
|
楊志新 |
| 國立臺灣大學 |
2006 |
Epidermal Growth Factor Receptor Mutations in Needle Biopsy/Aspiration Samples Predict Response to Gefitinib Therapy and Survival of Patients with Advanced Nonsmall Cell Lung Cancer
|
施金元; 高劍虹; 余忠仁; 楊志新; 張逸良; 蔡孟峰; 陳冠宇; 蘇文彬; 楊泮池; SHIH, JIN-YUAN; GOW, CHIEN-HUNG; YU, CHONG-JEN; YANG, CHIH-HSIN; CHANG, YIH-LEONG; TSAI, MENG-FENG; CHEN, KUAN-YU; SU, WEN-PIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Predictive Factors of Gefitinib Antitumor Activity in East Asian Advanced Non-Small Cell Lung Cancer Patients
|
張基晟; 蔡俊明; 陳焜結; 余忠仁; 施金元; 楊宗穎; 林京珮; 許正園; 邱昭華; 彭瑞鵬; 楊泮池; 楊志新; CHANG, GEE-CHEN; TSAI, CHUN-MING; CHEN, KUN-CHIEH; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, TSUNG-YING; LIN, CHING-PEI; HSU, JENG- YUAN; CHIU, CHAO-HUA; PENG, JUI-PENG; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2006 |
A Phase Ii Study of Gefitinib as First Line Treatment for Good Performance Advanced or Metastatic Non-Small Cell Lung Cancer in East Asian Patients
|
楊志新; 余忠仁; 陳焜結; 林宗哲; 郭頌鑫; 鄭安理; 楊泮池; YANG, CHIH-HSIN; YU, CHONG-JEN; CHEN, KUN-CHIEH; LIN, ZHONG-ZHE; KUO, SUNG-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Survival Outcome and Predictors of Gefitinib Antitumor Activity in East Asian Chemonaive Patients with Advanced Nonsmall Cell Lung Cancer
|
楊志新; 施金元; 陳焜結; 余忠仁; 楊宗穎; 林京珮; 蘇文彬; 高劍虹; 許駿; 張基晟; 楊泮池; YANG, CHIH-HSIN; SHIH, JIN-YUAN; CHEN, KUN-CHIEH; YU, CHONG-JEN; YANG, TSUNG-YING; LIN, CHING-PEI; SU, WEN-PIN; GOW, CHIEN-HUNG; HSU, CHIUN; CHANG, GEE-CHEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2006 |
Thoracic Radiotherapy for Stage Iv Non-Small Cell Lung Cancer
|
簡君儒; 楊志新; CHIEN, CHUN-RU; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
低氧對小鼠腫瘤生長及抗藥性之影響-建立動物模式(2/3)
|
楊志新 |
| 國立臺灣大學 |
2005 |
Docetaxel-Induced Recall Dermatitis on Previous Laser Treatment Sites
|
朱家瑜; 楊志新; CHU, CHIA-YU; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
A Phase Ii Study in Taiwan with Navelbine(Nvb) Oral in Combinatino with Cisplatin (C) in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients
|
余忠仁; 楊志新; 鄭安理; 楊泮池; YU, CHONG-JEN; YANG, CHIH-HSIN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Survival of Stage Iiib/Iv Non-Small Cell Lung Cancer Patients Who Received Chemotherapy but Did Not Participate in Clinical Trials
|
郭頌鑫; 楊志新; 余忠仁; 許駿; 鄭安理; 楊泮池; KUO, SUNG-HSIN; YANG, CHIH-HSIN; YU, CHONG-JEN; HSU, CHIUN; CHENG, ANN-LII; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Intrapatient Dose Escalation to 800 Mg/M2 Pemetrexed Is Safe and Feasible in Patients with Advanced Non-Small Cell Lung Cancer (Nsclc) Who Have Had Prior Chemotherapy
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2005 |
Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment
|
楊志新; 陳明君; 鄭安理; 徐志宏; 葉坤輝; 汪彭嘉康; 楊泮池; YANG, CHIH-HSIN; CHEN, MIN-CHUN; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; JACQUELINE, WHANG-PENG; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Gefitinib Reverses Chemotherapy Resistance in Gefitinib-Insensitive Multidrug Resistant Cancer Cells Expressing Atp-Binding Cassette Family Protein
|
楊志新; 黃靜如; 楊朝順; 朱玉娟; 鄭安理; 彭汪嘉康; 楊泮池; YANG, CHIH-HSIN; HUANG, CHING-JU; YANG, CHAO-SHUN; CHU, YU-CHUAN; CHENG, ANN-LII; WHANG-PENG, JACQUELINE; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Phase Ii Study of Weekly Vinorelbine and 24-H Infusion of High-Dose 5- Fluorouracil Plus Leucovorin as First-Line Treatment of Advanced Breast Cancer
|
葉坤輝; 楊志新; 鄭安理; YEH, KUN-HUEI; YANG, CHIH-HSIN; CHENG, ANN-LII |
| 國立臺灣大學 |
2005 |
A Phase Ii Trial of Docetaxel, Capecitabine, and Cisplatin as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
|
盧彥伸; 楊志新; 許駿; LU, YEN-SHEN; YANG, CHIH-HSIN; HSU, CHIUN |
| 國立臺灣大學 |
2005 |
Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status
|
蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN |
| 國立臺灣大學 |
2004 |
低氧對小鼠腫瘤生長及抗藥性之影響-建立動物模式(1/3)
|
楊志新 |
| 國立臺灣大學 |
2004 |
Differential Effects of Carboxyfullerene on Mpp+/Mptp-Induced Neurotoxicity
|
林滿玉; 楊志新; LIN, MAAN-YUH; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2004 |
Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract.
|
許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Gemzar Retrospective Economic Analysis of Clinical Trial (Great) in the Treatment of Nonsmall-Cell Lung Cancer in Taiwan
|
楊志新; 王麗惠; YANG, CHIH-HSIN; WANG, LI-HUI |
| 國立臺灣大學 |
2004 |
Cost Analysis of Lung Cancer Treatment in Taiwan
|
楊志新; 張啟仁; YANG, CHIH-HSIN; CHANG, CHEE-JEN |
| 國立臺灣大學 |
2004 |
Phase Ii Study of Combination Doxorubicin, Interferon-Alpha, and High- Dose Tamoxifen Treatment for Advanced Hepatocellular Carcinoma
|
盧彥伸; 許駿; 李啟誠; 郭頌鑫; 葉坤輝; 楊志新; 徐志宏; 吳貞瑤; 鄭安理; LU, YEN-SHEN; HSU, CHIUN; LI, CHI-CHENG; KUO, SUNG-HSIN; YEH, KUN-HUEI; YANG, CHIH-HSIN; HSU, CHIH-HUNG; WU, CHEN-YAO; CHENG, ANN-LII |
| 國立臺灣大學 |
2003 |
驗證以基因微陣列尋找之癌症抗藥基因在多重抗藥癌細胞的表現
|
楊志新 |
Showing items 161-185 of 209 (9 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
|
